1. Home
  2. WAT

as of 12-05-2025 12:31pm EST

$394.85
$1.52
-0.38%
Stocks Industrials Biotechnology: Laboratory Analytical Instruments Nasdaq

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

Chart Type:
Time Range:
Founded: 1958 Country:
United States
United States
Employees: N/A City: MILFORD
Market Cap: 17.4B IPO Year: 1995
Target Price: $382.14 AVG Volume (30 days): 553.7K
Analyst Decision: Buy Number of Analysts: 14
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 10.88 EPS Growth: 3.82
52 Week Low/High: $275.05 - $423.56 Next Earning Date: 11-04-2025
Revenue: $3,105,638,000 Revenue Growth: 6.90%
Revenue Growth (this year): 7.96% Revenue Growth (next year): 6.32%

AI-Powered WAT Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 18 hours ago

AI Recommendation

hold
Model Accuracy: 75.66%
75.66%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Waters Corporation News

WAT Breaking Stock News: Dive into WAT Ticker-Specific Updates for Smart Investing

All WAT News

Share on Social Networks: